Cue Biopharma, Inc. (CUE) Technical Analysis

🔺 Technical Setup

🎯 Decision Map

The next meaningful technical decision is likely to occur between support at 0.53 and resistance at 0.81. A cleaner push through resistance would improve continuation odds, while a loss of support would weaken the current thesis. Pattern invalidation sits near 0.37, so a violation there would materially change the current setup narrative.

📊 Technical Summary

Cue Biopharma, Inc. (CUE) closed at 0.61 (-1.46%). The chart remains in a constructive trend regime, with price holding above both the 50-day and 200-day moving averages. 20-day momentum is notably strong at +129.55%, with price remains inside its roughly 52-week range (0.18–0.93), while ATR14 volatility is elevated at roughly 19.63% of price. RSI(14) is 68.0, which reflects strong upside momentum, although the indicator is approaching stretched territory. RSI has been drifting lower recently, suggesting that upside momentum may be cooling slightly. MACD remains above its signal line, which keeps the momentum structure biased to the upside. The MACD histogram remains positive, although upside momentum is not accelerating further. Recent trading volume is running below its typical 20-day average, which suggests participation remains relatively muted. From a pattern perspective, the main active signal is Double top. The nearest decision zone is framed by support at 0.53 and resistance at 0.81. A move through resistance would improve the short-term technical tone, while a loss of support would weaken the current structure. Latest fundamentals snapshot: Revenue: 2.15M · Net income: -7.45M · EPS (basic): -0.07. The interactive view adds overlays, pattern context and broader chart structure for deeper review.

Explore more